Skip to main content
Program
#ScientificSessions26
Late-Breaking Science
Daily Coverage
Industry Highlights
Journeys
Latest Stories from Scientific Sessions
Patel: Solving science’s ‘last-mile problem’
Reports find multiple approaches improve outcomes after stroke
Late-breaking trials challenge conventional treatments to cardiovascular disease
Thank you to our sponsors and supporters
Keynote speaker: Missed opportunities could lead to great discoveries
Lessons from landmark trials
Nobel Laureate: Outcomes at the end of the road not taken
Econometric tools can help untangle knotty questions of cause and effect in medicine.
Sponsored
Join our Novo symposium exploring GLP-1RAs in cardiovascular disease
‘A change of heart: Rethinking cardiovascular care with GLP-1RAs’, featuring Stephen Greene, Leigh Perreault and Orly Vardeny
A lifeline for rural health
The Helmsley Charitable Trust and the American Heart Association celebrate 16-year collaboration on improved access to care, and $100 million giving milestone.
Putting clinical skills to the test
Bring clinical practice to life in the Simulation Zone, which offers immersive, hands-on learning experiences guided by expert faculty.
The hidden risks after Pulmonary Embolism
Clinicians urged to view CTEPH as part of the disease continuum that begins with acute Pulmonary Embolism.
Interesting Stories
Sponsored by Novo Nordisk Inc.
Join our Novo symposium exploring GLP-1RAs in cardiovascular disease
Sponsored by Edwards Lifesciences
Prompt referral can be lifesaving
Sponsored by BMS/J&J Alliance
Latest research on thromboembolic disease targets
Sponsored by Ionis Pharmaceuticals
Severe hypertriglyceridemia: see the data at Scientific Sessions, Booth #2802
Sponsored by Ionis Pharmaceuticals
Join us at the TRYNGOLZA® (olezarsen) Expert Theater at Scientific Sessions
Sponsored by Novartis Pharmaceuticals Corporation
What's New in LDL-C Management for ASCVD and Hypercholesterolemia?
Using mRNA to treat cardiovascular disease
mRNA is easier to sequence, scale and manufacture, and it carries fewer risks of insertional mutagenesis.
Connecting the dots in cardio-kidney-metabolic
New guideline emphasizes interdisciplinary approach for multi-organ patient care.
Cardiac CT offers a clearer picture of CVD
Advances in imaging move beyond coronary narrowing to reveal disease activity, characterize myocardial tissue and refine diagnosis.
CRISPR revolution nears mainstream cardiovascular care
The evolving technology is expected to become a cornerstone of medicine and transform how numerous diseases are treated.
What’s good for the heart is good for the brain
Educate your patients about the role of cardiovascular health strategies in reducing dementia.
Endothelium emerges as central driver of disease
Functioning as a dynamic organ system, it regulates inflammation, blood flow, thrombosis and numerous disease processes throughout the body.
As far as the AI can see
The cancer and arrhythmia conundrum
Distinguished Scientists for 2026
Bioengineered blood vessels offer hope for children
Distinguished Scientist pushes forward for equity
Paul Dudley White lecturer outlines profound tech impact on coronary care
Bringing expert cardiovascular care within reach
Pioneer showcases future of precision cardiology
Hot topics in cardiovascular gene therapy
Timing is everything in tricuspid regurgitation care
Surgical revascularization holds its ground in modern cardiac care
Welcome to Chicago!